Brief: Aequus Receives Positive Formulary Decision In British Columbia For Specialty Product
16/01/2020 14:37
Jan 16 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS RECEIVES POSITIVE FORMULARY DECISION IN BRITISH
COLUMBIA
FOR SPECIALTY PORTFOLIO PRODUCT
Source text for Eikon: ID:nGNX9yZLVw
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange